Innovative ETFs ChannelGreater Regulatory Scrutiny Could Weigh on Biotech ETFsBy Max ChenMarch 24, 2021
Innovative ETFs ChannelConsider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021By Max ChenDecember 31, 2020
FeaturedAs U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to RallyBy Ian YoungDecember 3, 2020
Equity ETF ChannelBiotech ETFs Poised for Gains after Moderna Vaccine NewsBy Ian YoungNovember 16, 2020
Tactical Allocation ChannelCan’t Get Enough Biotech Exposure in Your Portfolio?By Ben HernandezOctober 29, 2020
Leveraged & Inverse ChannelShort Sellers Back Off From Biotech ETFsBy Ben HernandezSeptember 28, 2020
Innovative ETFs ChannelBiotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 ResearchBy Max ChenJuly 7, 2020
Innovative ETFs ChannelBiotech ETFs Rally After Inovio Locks in DOD Coronavirus DealBy Max ChenJune 23, 2020
